Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Aleksandra Karabinowska"'
Autor:
Pawel P. Rubiś, Ewa M. Dziewięcka, Paweł Banyś, Małgorzata Urbańczyk-Zawadzka, Maciej Krupiński, Małgorzata Mielnik, Jacek Łach, Andrzej Ząbek, Sylwia Wiśniowska-Śmiałek, Piotr Podolec, Aleksandra Karabinowska, Katarzyna Holcman, Ann C. Garlitski
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The current stratification of arrhythmic risk in dilated cardiomyopathy (DCM) is sub-optimal. Cardiac fibrosis is involved in the pathology of arrhythmias; however, the relationship between cardiovascular magnetic resonance (CMR) derived ext
Externí odkaz:
https://doaj.org/article/8bf380add63042d392167fadb974cfbe
Autor:
Ewa Dziewięcka, Matylda Gliniak, Mateusz Winiarczyk, Arman Karapetyan, Sylwia Wiśniowska‐Śmiałek, Aleksandra Karabinowska, Marcin Dziewięcki, Piotr Podolec, Paweł Rubiś
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2455-2467 (2020)
Abstract Aims The aims of this paper were to investigate the analytical performance of the nine prognostic scales commonly used in heart failure (HF), in patients with dilated cardiomyopathy (DCM), and to develop a unique prognostic model tailored to
Externí odkaz:
https://doaj.org/article/bce7021e5dde4f499cca668d21cc86aa
Autor:
Paweł Rubiś, Ewa Dziewięcka, Magdalena Szymańska, Robert Banyś, Małgorzata Urbańczyk-Zawadzka, Maciej Krupiński, Małgorzata Mielnik, Sylwia Wiśniowska-Śmiałek, Aleksandra Karabinowska, Piotr Podolec, Mateusz Winiarczyk, Matylda Gliniak, Monika Kaciczak, Jan Robak, Arman Karapetyan, Ewa Wypasek
Publikováno v:
Cells, Vol 10, Iss 6, p 1295 (2021)
The relationship between circulating fibrosis-related molecules and magnetic resonance-assessed cardiac fibrosis in dilated cardiomyopathy (DCM) is poorly understood. To compare circulating biomarkers between DCM patients with high and low fibrosis b
Externí odkaz:
https://doaj.org/article/7dd31ea3be2144dea2fad815f26d079a
Autor:
Paweł Rubiś, Mateusz Winiarczyk, Sylwia Wiśniowska-Śmiałek, Marcin Dziewięcki, Matylda Gliniak, Aleksandra Karabinowska, Arman Karapetyan, Ewa Dziewięcka, Piotr Podolec
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2455-2467 (2020)
Aims The aims of this paper were to investigate the analytical performance of the nine prognostic scales commonly used in heart failure (HF), in patients with dilated cardiomyopathy (DCM), and to develop a unique prognostic model tailored to DCM pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8304f8aa5c830d8f927da6dca04459
https://doaj.org/article/bce7021e5dde4f499cca668d21cc86aa
https://doaj.org/article/bce7021e5dde4f499cca668d21cc86aa
Autor:
Aleksandra Karabinowska-Małocha, Ewa Dziewięcka, Paweł Banyś, Małgorzata Urbańczyk-Zawadzka, Maciej Krupiński, Małgorzata Mielnik, Jacek Łach, Aleksandra Budkiewicz, Piotr Podolec, Łukasz Żydzik, Sylwia Wiśniowska-Śmiałek, Katarzyna Holcman, Magdalena Kostkiewicz, Paweł Rubiś
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 2; Pages: 294
Non-sustained ventricular tachycardia (nsVT) creates the electrical basis for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We aimed to evaluate the relationship between interstitial fibrosis on cardiac magnetic resonance (CMR) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3121a186708da6c91093bedf74364ae2
Autor:
Ewa Dziewięcka, Mateusz Winiarczyk, Sylwia Wiśniowska-Śmiałek, Aleksandra Karabinowska-Małocha, Matylda Gliniak, Jan Robak, Monika Kaciczak, Przemysław Leszek, Małgorzata Celińska-Spodar, Marcin Dziewięcki, Paweł Rubiś
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 2; Pages: 236
Background: One of the most common causes of heart failure is dilated cardiomyopathy (DCM). In DCM, the mortality risk is high and reaches approximately 20% in 5 years. A patient’s prognosis should be established for appropriate HF management. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8b77c8604af1d4efa46afe92401ac1
https://ruj.uj.edu.pl/xmlui/handle/item/290219
https://ruj.uj.edu.pl/xmlui/handle/item/290219
Autor:
Wojciech Szot, K Mroz, Ewa Dziewięcka, P Rubis, S Wisniowska-Smialek, M. Hlawaty, Aleksandra Karabinowska, Magdalena Kostkiewicz, A Lesniak-Sobelga, Adam Stępień, Katarzyna Holcman, K Graczyk, Piotr Podolec
Publikováno v:
European Heart Journal. 42
Background Amyloid cardiomyopathy (CA) it is more frequently diagnosed due to rapidly developing imaging modalities. Misfolding of transthyretin (TTR) is the source of two distinct forms of amyloidosis (ATTR): acquired wild-type (ATTRwt) and heredita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5f1eb09fc7ca6e5ce0708fcc68d9c57
https://doi.org/10.1093/eurheartj/ehab724.1817
https://doi.org/10.1093/eurheartj/ehab724.1817
Autor:
Adam Stępień, Ewa Dziewięcka, S Wisniowska-Smialek, M. Hlawaty, Piotr Podolec, Magdalena Kostkiewicz, Aleksandra Karabinowska, Wojciech Szot, K Mroz, A Lesniak-Sobelga, P Rubis, Katarzyna Holcman, K Graczyk
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: Other. Main funding source(s): Pfizer Research Grant (ID#57165999) Background Misfolding of transthyretin (TTR) is the source of two distinct forms of amyloidosis (ATTR): acquired or wild-type (ATTRwt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9249ad7c555d9a7a24476e794f5c3d2
https://doi.org/10.1093/ehjci/jeab111.056
https://doi.org/10.1093/ehjci/jeab111.056
Autor:
Lusine Khachatryan, Ann C. Garlitski, Piotr Podolec, Ewa Wypasek, Andrzej Gackowski, Ewa Dziewięcka, Aleksandra Karabinowska, Katarzyna Holcman, Paweł Rubiś, Maria Szymonowicz, Sylwia Wiśniowska-Śmiałek
BACKGROUND Galectin-3 is an emerging biomarker in cardiovascular disease. Myocardial galectin-3 is involved in the pathology of cardiac fibrosis; however, the role of circulating galectin-3 is not yet established. OBJECTIVES To assess the relationshi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20b282ebb1cf02974e2573fd0b046b6c
https://ruj.uj.edu.pl/xmlui/handle/item/271186
https://ruj.uj.edu.pl/xmlui/handle/item/271186
Autor:
A Karapetyan, S Wisniowska-Smialek, Piotr Podolec, M Winiarczyk, Aleksandra Karabinowska, M Gliniak, Ewa Dziewięcka, P Rubis
Publikováno v:
European Heart Journal. 41
Introduction The reliable identification of patients with heart failure (HF) and high mortality risk is crucial for treatment optimalization and prognostication, especially in younger population in dilated cardiomyopathy (DCM). However, the profile o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c94ce3a01800847fdf401a66f81dcf
https://doi.org/10.1093/ehjci/ehaa946.2099
https://doi.org/10.1093/ehjci/ehaa946.2099